1 Symptom score/IPSS (points) Show forest plot

2

342

Mean Difference (IV, Random, 95% CI)

‐4.91 [‐6.29, ‐3.53]

2 Symptom score/Boyarsky quality of life scale (points) Show forest plot

1

200

Mean Difference (IV, Random, 95% CI)

‐4.50 [‐6.05, ‐2.95]

3 Patient overall evaluation of efficacy (rated very good or good). Show forest plot

1

80

Risk Ratio (M‐H, Random, 95% CI)

8.25 [3.22, 21.13]

4 Physician overall evaluation of efficacy (rated very good or good). Show forest plot

1

80

Risk Ratio (M‐H, Random, 95% CI)

11.00 [3.67, 32.97]

5 Nocturia (times per evening) Show forest plot

1

80

Mean Difference (IV, Random, 95% CI)

‐1.00 [‐1.75, ‐0.25]

6 Peak urine flow (mls/s) Show forest plot

4

474

Mean Difference (IV, Random, 95% CI)

3.91 [0.91, 6.90]

7 Peak urine flow (mls/s): sensitivity analysis Show forest plot

3

421

Mean Difference (IV, Random, 95% CI)

5.13 [2.37, 7.89]

8 Residual volume (mls) Show forest plot

4

475

Mean Difference (IV, Random, 95% CI)

‐28.62 [‐41.42, ‐15.83]

9 Residual volume (mls): sensitivity analysis Show forest plot

3

422

Mean Difference (IV, Random, 95% CI)

‐29.97 [‐38.27, ‐21.66]

10 Prostate size (cc) Show forest plot

2

216

Mean Difference (IV, Random, 95% CI)

‐6.19 [‐15.29, 2.91]